Cargando…

Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells

Variability in activity of CYP2C9, which is involved in the metabolism of approximately 15% of current therapeutic drugs, is an important contributor to interindividual differences in drug response. To evaluate the functional alternations of CYP2C9(*)2, CYP2C9(*)3, CYP2C9(*)8, CYP2C9(*)11 and CYP2C9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Huihui, Wei, Zhiyun, Yan, Yucai, Xiong, Yuyu, Zhang, Xiaoqing, Shen, Lu, Ruan, Yunfeng, Wu, Xi, Xu, Qingqing, He, Lin, Qin, Shengying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843492/ https://www.ncbi.nlm.nih.gov/pubmed/27199745 http://dx.doi.org/10.3389/fphar.2016.00098

Ejemplares similares

A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China – A Basis for Personalized Therapy
por: Wu, Zhenqiang, et al.
Publicado: (2013)

Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a Patient
por: Zhou, Xiao-Yang, et al.
Publicado: (2021)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
por: Wang, Cong, et al.
Publicado: (2018)

Frequency of CYP2D6 Alleles Including Structural Variants in the United States
por: Del Tredici, Andria L., et al.
Publicado: (2018)

Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro
por: Zhou, Xiao-Yang, et al.
Publicado: (2019)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022)

CYP2E1 overexpression protects COS-7 cancer cells against ferroptosis
por: Caro, Andres A., et al.
Publicado: (2023)

Identification and Analysis of CYP7A1, CYP17A1, CYP20A1, CYP27A1 and CYP51A1 in Cynomolgus Macaques
por: UNO, Yasuhiro, et al.
Publicado: (2014)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line
por: Lee, Hye Ja, et al.
Publicado: (2011)

Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants
por: Gaedigk, Andrea, et al.
Publicado: (2010)

Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population
por: Huo, Ran, et al.
Publicado: (2012)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
por: Johansson, Maria, et al.
Publicado: (2014)

Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping
por: Rubben, Kaat, et al.
Publicado: (2022)

The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)‐Warfarin
por: Wanounou, Maor, et al.
Publicado: (2022)

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region
por: Salles, Paula Ferreira, et al.
Publicado: (2021)

From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of CYP2C19
por: Graansma, Lonneke J., et al.
Publicado: (2023)

CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6(*)15 and (*)35 Genotyping
por: Riffel, Amanda K., et al.
Publicado: (2016)

Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions
por: Boone, Erin C., et al.
Publicado: (2020)

Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing
por: Turner, Amy J., et al.
Publicado: (2023)

Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform
por: Kabir, Md, et al.
Publicado: (2022)

Influence of Genetic Admixture Components on CYP3A5*3 Allele-Associated Hypertension in Amerindian Populations From Northwest Mexico
por: Galaviz-Hernández, Carlos, et al.
Publicado: (2020)

Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
por: Prado, Mayara J., et al.
Publicado: (2022)

Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance
por: Swart, Marelize, et al.
Publicado: (2014)

The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?
por: Glubb, Dylan M., et al.
Publicado: (2017)

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
por: Molden, Espen, et al.
Publicado: (2021)

A frequent CYP2D6 variant promotes skipping of exon 3 and reduces CYP2D6 protein expression in human liver samples
por: Collins, Joseph M., et al.
Publicado: (2023)

Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions
por: Kong, Qihui, et al.
Publicado: (2023)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

MicroRNA-10a-3p Improves Cartilage Degeneration by Regulating CH25H-CYP7B1-RORα Mediated Cholesterol Metabolism in Knee Osteoarthritis Rats
por: Li, Xiaochen, et al.
Publicado: (2021)

Comparison of CYP2C9 Activity in Ethiopian and Non-Ethiopian Jews Using Phenytoin as a Probe
por: Abu Ghosh, Zahi, et al.
Publicado: (2020)

Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations
por: Suarez-Kurtz, Guilherme
Publicado: (2023)

“Late” Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn
por: Passia, Evangelia, et al.
Publicado: (2017)

Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
por: Xiao-Rong, Lu, et al.
Publicado: (2021)

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities
por: Hurkmans, Evelien G. E., et al.
Publicado: (2020)

The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping
por: Wen, Ya Feng, et al.
Publicado: (2022)

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro
por: Zou, Li-Li, et al.
Publicado: (2023)

Development of a genotyping tool for a functionally relevant CYP2C19 allele (Phe100Asn, Ala103Val and Ile112Leu) in cynomolgus macaques
por: UNO, Yasuhiro, et al.
Publicado: (2015)

Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism
por: Tang, Peng-fei, et al.
Publicado: (2020)

In vitro and in vivo assessment of CYP2C9-mediated herb–herb interaction of Euphorbiae Pekinensis Radix and Glycyrrhizae Radix
por: Wang, Xinmin, et al.
Publicado: (2014)

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
por: Krall, Paola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4vd52ebim3fo3fk0fos5f9ice